Enliven Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $52M | 2.6M | 20.47 |
| 2025-06-30 | $48M | 2.4M | 20.06 |
| 2025-03-31 | $39M | 2.0M | 19.68 |
| 2024-12-31 | $45M | 2.0M | 22.50 |
| 2024-09-30 | $49M | 1.9M | 25.54 |
| 2024-06-30 | $43M | 1.8M | 23.37 |
| 2024-03-31 | $21M | 1.2M | 17.59 |
| 2023-12-31 | $17M | 1.2M | 13.84 |
| 2023-09-30 | $16M | 1.2M | 13.66 |
| 2023-06-30 | $23M | 1.1M | 20.41 |
| 2023-03-31 | $3.3M | 152k | 21.90 |